These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33991850)

  • 21. Methylation markers of malignant potential in meningiomas.
    Vengoechea J; Sloan AE; Chen Y; Guan X; Ostrom QT; Kerstetter A; Capella D; Cohen ML; Wolinsky Y; Devine K; Selman W; Barnett GH; Warnick RE; McPherson C; Chiocca EA; Elder JB; Barnholtz-Sloan JS
    J Neurosurg; 2013 Oct; 119(4):899-906. PubMed ID: 23930849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
    Goutagny S; Nault JC; Mallet M; Henin D; Rossi JZ; Kalamarides M
    Brain Pathol; 2014 Mar; 24(2):184-9. PubMed ID: 24261697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Molecular and Immunological Landscape of Meningiomas.
    Lotsch C; Warta R; Herold-Mende C
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
    Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
    Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MOLECULAR PATHOLOGY OF MENINGIOMAS].
    Murnyák B; Csonka T; Hortobágyi T
    Ideggyogy Sz; 2015 Sep; 68(9-10):292-300. PubMed ID: 26665490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meningioma: an update.
    Lusis E; Gutmann DH
    Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
    Lucas CG; Devine P; Solomon DA; Giannini C; Reifenberger G; Dahiya S; Caccamo D; Perry A
    J Neuropathol Exp Neurol; 2021 Sep; 80(8):764-768. PubMed ID: 34128073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas.
    Tabernero M; Jara-Acevedo M; Nieto AB; Caballero AR; Otero A; Sousa P; Gonçalves J; Domingues PH; Orfao A
    BMC Med Genet; 2013 Oct; 14():114. PubMed ID: 24171707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization.
    Begnami MD; Rushing EJ; Santi M; Quezado M
    Int J Surg Pathol; 2007 Apr; 15(2):110-5. PubMed ID: 17478763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
    Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
    Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma.
    Patel KS; Kejriwal S; Sun MM; Thammachantha S; Duong C; Chan A; Cherian N; Romiyo P; Gordon LK; Yong W; Wadehra M; Yang I
    J Neurooncol; 2020 Mar; 147(1):15-24. PubMed ID: 31981014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.
    Maillo A; Orfao A; Espinosa AB; Sayagués JM; Merino M; Sousa P; Lara M; Tabernero MD
    Neuro Oncol; 2007 Oct; 9(4):438-46. PubMed ID: 17704362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.
    Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W
    Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5.
    Abedalthagafi MS; Merrill PH; Bi WL; Jones RT; Listewnik ML; Ramkissoon SH; Thorner AR; Dunn IF; Beroukhim R; Alexander BM; Brastianos PK; Francis JM; Folkerth RD; Ligon KL; Van Hummelen P; Ligon AH; Santagata S
    Oncotarget; 2014 Nov; 5(21):10596-606. PubMed ID: 25347344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CNS Resident Award. Malignant meningiomas frequently lose multiple chromosomal regions in addition to 22q: putative meningioma progression loci identified by comparative genomic hybridization.
    Metzger AK; Minn YA; Lieberman D; Bollen AW; Wilson CB; Feuerstein BG
    Clin Neurosurg; 1999; 45():6-7. PubMed ID: 10461493
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
    Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM
    J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.